Brainstem BDNF neurons are downstream of GFRAL/GLP1R signalling.
Nat Commun · 2024
Last updated 2026-05-28In mice, a specific brain pathway involving BDNF neurons in the brainstem is linked to the weight-loss effects of GLP-1 drugs like Exendin-4 and the hormone GDF15. These neurons are activated by signals from brainstem cells that respond to both GLP-1 and GDF15. Activating these BDNF neurons alone was enough to reduce food intake and increase fat burning in the short term.
AI summary of the abstract below.
| Journal | Nat Commun, 2024 |
|---|---|
| Citations | 9 |
| Relative citation ratio | 1.55 |
| NIH percentile | 66 |
| Molecules | — |
Abstract
Growth differentiation factor 15, GDF15, and glucagon-like peptide-1 (GLP-1) analogues act through brainstem neurons that co-localise their receptors, GDNF-family receptor α-like (GFRAL) and GLP1R, to reduce food intake and body weight. However, their use as clinical treatments is partially hampered since both can also induce sickness-like behaviours, including aversion, that are mediated through a well-characterised pathway via the exterolateral parabrachial nucleus. Here, in mice, we describe a separate pathway downstream of GFRAL/GLP1R neurons that involves a distinct population of brain-derived neurotrophic factor (BDNF) cells in the medial nucleus of the tractus solitarius. Thus, BDNF neurons are required for the weight-reducing actions of both GDF15 and the GLP1RA, Exendin-4. Moreover, acute activation of BDNF neurons is sufficient to reduce food intake and drive fatty acid oxidation and might provide a route for longer-term weight loss.
Verbatim abstract via PubMed 39737892 ↗